Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Non-Current Assets: 2011-2025

Historic Non-Current Assets for Mimedx Group (MDXG) over the last 14 years, with Sep 2025 value amounting to $64.9 million.

  • Mimedx Group's Non-Current Assets fell 9.56% to $64.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.9 million, marking a year-over-year decrease of 9.56%. This contributed to the annual value of $72.0 million for FY2024, which is 3.69% down from last year.
  • Mimedx Group's Non-Current Assets amounted to $64.9 million in Q3 2025, which was down 7.60% from $70.2 million recorded in Q2 2025.
  • Mimedx Group's Non-Current Assets' 5-year high stood at $82.8 million during Q1 2024, with a 5-year trough of $34.5 million in Q3 2023.
  • Its 3-year average for Non-Current Assets is $62.6 million, with a median of $70.3 million in 2025.
  • Its Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 127.19% in 2024, then declined by 15.12% in 2025.
  • Mimedx Group's Non-Current Assets (Quarterly) stood at $39.4 million in 2021, then dropped by 5.52% to $37.2 million in 2022, then soared by 100.86% to $74.8 million in 2023, then declined by 3.69% to $72.0 million in 2024, then fell by 9.56% to $64.9 million in 2025.
  • Its last three reported values are $64.9 million in Q3 2025, $70.2 million for Q2 2025, and $70.3 million during Q1 2025.